文献速递心脏核医学

CT衰减校正门控SPECT心肌灌注显像在预测肺动脉高压中的作用

Role of CT attenuation correction gated SPECT MPI in prediction of pulmonary hypertension.
PubMed 文献 · J Nucl Cardiol · 2023-12-01

回顾性研究纳入207例在最多1个月内完成经胸超声心动图和MPI的冠状动脉患者,评估非对比CT测量主肺动脉直径的可靠性及门控参数预测肺动脉高压的价值。以超声心动图RVSP≥36 mmHg定义肺动脉高压,120例RVSP≥36、87例RVSP<36。非对比CT的MPAd、门控LV形状指数及非AC SPECT-MPI的RV/LV摄取比与RVSP显著相关。

要点

  • 以超声心动图RVSP≥36 mmHg定义肺动脉高压,207例中120例RVSP≥36、87例RVSP<36。
  • 非对比CT测得的MPAd、门控LV形状指数及非AC SPECT-MPI的RV/LV摄取比与RVSP显著相关。
  • RVSP≥36 mmHg组的负荷与静息RV/LV摄取比、MPAd、LV收缩末期与舒张末期形状指数显著高于RVSP<36 mmHg组。

核心结论

  • 使用CT衰减校正的门控SPECT-MPI可通过可靠估算MPAd以及确定RV/LV摄取比和形状指数来预测肺动脉高压,为这一检查在心脏病患者中提供额外临床价值。

研究设计与样本

  • 回顾性研究共纳入207例患者,均在最多1个月内完成经胸超声心动图和MPI。
  • 肺动脉高压定义为超声心动图RVSP≥36 mmHg,并计算峰值三尖瓣反流速度作为肺动脉高压标准。
  • 207例中120例RVSP≥36、87例RVSP<36;191例PTRV≤3.4 m/s、16例PTRV>3.4 m/s。
  • 各组间就超声心动图结果与MPI参数(含CT-AC与不含CT-AC)进行非关联比较,参数包括CT-derived MPAd、RV/LV摄取比、形状指数及室间隔壁运动和增厚评分。

主要发现

  • 超声心动图肺动脉高压基准指标RVSP与非对比CT-derived MPAd、门控研究LV形状指数及非AC SPECT-MPI的RV/LV摄取比之间存在显著关联。
  • RVSP≥36 mmHg组的负荷与静息RV/LV摄取比、MPAd、LV收缩末期和舒张末期形状指数显著高于RVSP<36 mmHg组。

关键数值与推荐

  • 肺动脉高压的超声心动图标准为RVSP≥36 mmHg。
  • PTRV分组标准为≤3.4 m/s与>3.4 m/s,分别对应191例和16例。

临床怎么用

  • 原文结论认为,使用CT-AC的门控SPECT-MPI可通过可靠估算MPAd以及确定RV/LV摄取比和形状指数来预测肺动脉高压,为心脏病患者提供额外临床价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To elucidate the value of gated SPECT-MPI using CT attenuation correction (AC) for prediction of pulmonary hypertension (PHT) in coronary patients by estimation of reliability of non-contrast CT in measurement of main pulmonary artery diameter (MPAd) as well as by assessment of potential predictive role of gated parameters as beneficial accessory findings. BACKGROUND: Contrast-enhanced CT is known as an accurate tool for assessment of MPAd to predict PHT. [1] The low-dose non-contrast CT which is used for AC in MPI study, however, has an unclear value in precise vascular diameter measurement; it is also uncertain whether gated parameters could help to predict PHT. METHODS AND PATIENTS: A total of 207 patients, who had a transthoracic echocardiography and MPI with an interval of maximum one month, underwent this retrospective study. PHT was defined as a RVSP ≥36 mmHg by echocardiography; peak tricuspid regurgitation velocity (PTRV) was also calculated to use as a criterion for PHT. Of all subjects, 120 had RVSP ≥ 36 and 87 showed RVSP < 36; there also were 191 and 16 patients with PTRV ≤ 3.4 m/s and >3.4 m/s, respectively. Comparison was made unconnectedly between each group regarding the echocardiography results with the MPI parameters, with and without CT-AC, including MPAd derived from CT as well as RV/LV uptake ratio, shape index and septal wall motion and thickening scores to define the best indicators of PHT. RESULTS: There was a significant association between established benchmark of PHT in echocardiography (RVSP), with MPAd derived from non-contrast CT as well as with LV shape index from gated study and RV/LV uptake ratio acquired from non-AC SPECT-MPI. Also, stress and rest RV/LV uptake ratio, MPAd, LV end-systolic and LV end-diastolic shape indexes are significantly higher in patients with RVSP ≥ 36 mmHg compare to patients with RVSP < 36 mmHg. CONCLUSIONS: Gated-SPECT-MPI using CT-AC can predict PHT by reliable estimation of MPAd as well as by defining RV/LV uptake ratio and shape index, providing an added clinical value for this invaluable modality in cardiac patients.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Yaghoobi N, Maghsudi M, Malek H, et al. Role of CT attenuation correction gated SPECT MPI in prediction of pulmonary hypertension. J Nucl Cardiol. 2023. PMID: 38237365. doi:10.1016/j.nuclcard.2023.101777

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。